Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
about
Selective gene silencing by viral delivery of short hairpin RNAProfile of Eckard Wimmer. Interview by Sujata GuptaVirus attenuation by genome-scale changes in codon pair biasSynthetic viruses: a new opportunity to understand and prevent viral diseaseTherapeutic Use of Native and Recombinant EnterovirusesNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesPreclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastomaA high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.A host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus/poliovirus chimera, PV1(RIPO).Cytolytic replication of echoviruses in colon cancer cell linesAttenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis.Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.New perspectives in cancer virotherapy: bringing the immune system into play.Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?Initiation of protein-primed picornavirus RNA synthesis.Polio vaccination: past, present and future.Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirusOncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.Oncolytic poliovirus against malignant glioma.Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses.Gene therapy as a potential tool for treating neuroblastoma-a focused review.Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.Replication of poliovirus requires binding of the poly(rC) binding protein to the cloverleaf as well as to the adjacent C-rich spacer sequence between the cloverleaf and the internal ribosomal entry siteExtensive recoding of dengue virus type 2 specifically reduces replication in primate cells without gain-of-function in Aedes aegypti mosquitoesThe Practical Consideration of Poliovirus as an Oncolytic Virotherapy
P2860
Q21245112-F9C4C652-A671-416E-A1EF-F4D0E04881C2Q24624402-0B3FB478-8E2E-4CAC-A19E-0A0E05A63AF7Q24644457-A54AFA48-98E0-43E5-8F49-EA493B21427BQ24650817-A4592F7E-E05D-405F-9C3B-E830E2560381Q26767082-1A3B7BDB-108F-4B05-8854-0D30A79CAEBFQ26825652-D4FA4C6F-C802-4DAD-8B63-B2E9FB88250DQ27303714-9CD9EEEF-0A39-44CB-A6FD-F25BC286A42DQ33554262-9CD8D200-C39F-4FFF-BB3E-C46EF219691EQ33797119-FDB76499-772C-4810-B531-DC60E2938BB0Q34421151-EB051AD9-CF88-458A-8521-1DA4B6AE0588Q35077681-028BED0B-EC00-4550-994D-248F6A2313DFQ35541517-DBA83B6E-7D1C-442C-87DB-6659DB8D6F86Q35826143-26E45676-390A-4A36-8EA1-E0D6060F2AB7Q35975620-E55C0F11-C90A-4539-8EA5-92071FE27477Q37001439-BF86E03B-44C9-4F0D-B919-49C43BB217C0Q37773253-FE4676E0-F764-449E-8041-D6D859D3DB9DQ37834445-82DF322C-3BE3-4863-B1E8-B10DB48A1D61Q38319798-D0F23222-4DC4-4DB1-87AF-BD721274479EQ38396773-6C8EE8EE-AA4F-4198-917D-4A9170595260Q38530234-0808CF19-D06A-47C5-B5B5-010E4B90C0C7Q38536420-56E5E3E7-95EC-4DAC-B9BD-A1666C59A495Q38636508-EFD8FE1E-4CD1-4D2F-B253-33FFF5601FACQ38736703-15FDC36F-C312-4DA2-AE7E-6919343FE596Q38808728-8A0CEFC9-1919-48DC-9C9B-34971A17198BQ39188198-FB80EF32-5660-4541-A5E6-DC3B5E81E243Q42638109-A6DBBB97-69C2-4887-94B9-A02C92C08B75Q57009189-66AE14A7-3B9C-4CB1-A884-8110BC902956Q57012283-BF604058-54A3-4DCC-A527-BDEAD34DAC57
P2860
Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@en
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@nl
type
label
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@en
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@nl
prefLabel
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@en
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@nl
P2093
P1433
P1476
Oncolytic treatment and cure o ...... irus-susceptible animal model.
@en
P2093
Hidemi Toyoda
Jeronimo Cello
Steffen Mueller
P304
P356
10.1158/0008-5472.CAN-06-3713
P407
P577
2007-03-01T00:00:00Z